复星医药小分子癌症1类新药“芦沃美替尼”获批上市

动脉网
May 29, 2025

复星医药新药芦沃美替尼获批上市,用于治疗朗格汉斯细胞组织细胞增生症和组织细胞肿瘤成人患者等,该药是MEK1/2选择性抑制剂,可抑制肿瘤生长。临床试验数据显示,其对成人组织细胞肿瘤患者有显著疗效。

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10